Pharmaceutical Excipients Market is expected to reach US$ 9,873.53 Mn by 2027
                     Pharmaceutical Excipients Market
The pharmaceutical 
excipients market was 
valued at US$ 6,521.74 
million in 2019 and is 
projected to reach US$ 
9,873.53 million by 2027; 
it is expected to grow at a 
CAGR of 5.5% from 2020 
to 2027.
Current and future Market Scenario
 According to The Insight Partners market research study titled “Pharmaceutical Excipients Market to 2027 – COVID-19 Impact 
and Global Analysis – by Product, Functionality, and Type of Formulation,” the global pharmaceutical excipients market is 
expected to reach US$ 9,873.53 million by 2027 from US$ 6,521.74 million in 2019. The market is estimated to grow at a CAGR 
of 5.5% from 2020 to 2027. The report highlights the trends prevalent in the global pharmaceutical excipients market and the 
factors driving the market along with those that act as deterrents to its growth.
 Based on product, the pharmaceutical excipients market is segmented into organic chemicals, inorganic chemicals, and others 
products. In 2019, the organic chemicals segment held the largest market share, and is expected to dominate the market during 
the forecast period due to the rise in the use of organic chemicals in various formulations in the pharmaceutical industry. 
Moreover, the same segment is anticipated to grow at the fastest rate during the forecast period.
 Driving factors, such as surge in generics market and growth of the pharmaceutical market backed by multi-functional excipients, 
are expected to boost the market growth over the years. However, cost and time intensive drug development process is likely to 
pose a negative impact on the market growth.
Current and future Market Scenario
 The coronavirus pandemic is estimated to have significant impact on the pharmaceutical excipients market. Majority of the 
pharmaceutical companies around the globe are engaged in the development of vaccines for coronavirus. However, this shift 
of focus is anticipated to have a negative impact on the other segments of the market. Also, disruptions in supply chain 
caused due to halt in global operations are projected to have an adverse impact on the market.
 DuPont de Nemours, Inc.; Roquette Frères; Ashland Global Holdings, Inc.; BASF SE; Evonik Industries AG; Associated British 
Foods Plc; Archer Daniels Midland Company; Lubrizol Corporation; Croda International Plc; and DFE Pharma are among the 
prominent players operating in pharmaceutical excipients market.
 The market players are focused toward bringing new and innovative products and services to sustain their position in the 
market. For instance, in June, 2020, Evonik launched RESOMER Precise platform of custom functional excipients to precisely 
control the release profile of parenteral drug products. Such developments are expected to help the market growth during 
the forecast period.
Key Findings
Market Insights
Excipients are an integral component of pharmaceutical products that primarily determine the structure of dosage type and its 
role in delivering drugs. Excipients significantly affect the process ability, aesthetics, efficiency, and patient compliance with the 
dosage form. Thus, the use of excipients in a formulation requires an assurance and a clear understanding of their quality, 
safety, and performance attributes. The principal role of excipients is to support patient acceptability, enhance stability, 
bioavailability, and assist in the effectiveness. The generics industry has witnessed a remarkable run over the last decade, with 
companies achieving above-average shareholder returns. Generic drugs are the alternatives to branded drugs with the same 
dosage form, safety, strength, administration route, and quality. As per stats provided by the India Brand Equity Foundation 
(IBEF), India is among the largest supplier of generic medicines and the country's generic medicines account for ~20% of the 
global exports of generic medicines. In 2017, Indian pharmaceutical companies received 300 generic drug approvals in the US. 
Thus, the worldwide rise in the sale of generic drugs has increased the demand for prescription excipients. The market consists 
of revenues made by companies manufacturing pharmaceutical excipients through the sales of these excipients. In addition, 
many blockbuster drugs are on the brink of losing their patents. The patent cliff has resulted in billions dollars’ worth of brand 
drug sales losing patent protection. Generic drug companies are free to produce their own replicas when patents expire, which 
can cost up to 80% less than the originals, eventually resulting in a sharp and sudden loss of profits for the companies that 
developed them. Use of functionality excipients, allows pharmaceutical firms to extend patents.
Key Findings
The need to cut prices, generic competition, and lack of innovation are weighing the pharmaceutical industry down. 
Excipients have become an integral element in the manufacturing of tablets as these provide improved functionality in 
pharmaceuticals and aid in drug development and innovation, which, in turn help improve patent life at a lower cost. 
Excipients play a significant role in helping pharmaceutical manufacturers by increasing treatment effectiveness and 
compliance.
Growth of the Pharmaceutical Market Backed By Multi-Functional Excipients
Multifunctional excipient refers to excipients playing several roles in a dosage type or a drug delivery method. Several APIs 
(Active Pharmaceutical Ingredients) demonstrate low dissolution rates and poor solubility in aqueous condition. Oral 
bioavailability of these compounds is low due to poor solubility. In order to increase the bioavailability of these poorly 
soluble products, formulation methods are used to improve their aqueous solubility and dissolution. ~90% of newly 
discovered therapeutic compounds in the developmental process are reported to exhibit low aqueous solubility. 
Additionally, ~40% of new medicines prescribed to patients in hospitals are estimated to have relatively poor aqueous 
solubility. These drugs require functional excipients to help resolve their weak physico-chemical properties.
Key Findings
Multi-functional excipients are used to generate dosage forms that can minimize the number of 
doses by adjusting the rate of drug release or enhancing drug delivery by targeting the 
gastrointestinal tract where drug absorption is maximum. In addition, functional excipients are 
used to re-formulate existing drugs to create efficient and cost-effective products. As the 
production of novel drug delivery systems is progressing, sophisticated excipients are required to 
impart these properties to the final product. Moreover, increasing prevalence of chronic diseases 
and a growing propensity to consume oral formulations are some of the factors anticipated to fuel 
demand for multi-functional excipients in the pharmaceutical industry. Multifunctional excipients 
play an important role in the development of intelligent drug delivery systems, thereby leading to 
the improvement of the achieved therapeutic effect.
Strategic Insights
Product launch and mergers and acquisitions are observed as the most adopted strategy in global 
pharmaceutical excipients industry. A few recent key product developments are listed below:
2020: Evonik launched RESOMER Precise platform of custom functional excipients to precisely 
control the release profile of parenteral drug products.
Key Findings
Strategic Insights
2020: IMCD, a leading specialty chemical distributor, and DuPont Health and Nutrition have agreed 
to expand their Pharmaceutical Ingredients’ partnership to the Middle East region with IMCD 
servicing and supporting the relevant countries from their newly established office in Dubai.
2020: Croda International Plc confirmed that it has successfully completed the acquisition of 
Fragrance Spanish Topco, S.L., trading as Iberchem, a leading global fragrances and flavours 
company.
 Download PDF Brochure @ https://www.theinsightpartners.com/sample/TIPRE00003534/
Market Segments
By Functionality
• Fillers and Diluents
By Product By Type of Formulation
•
• Suspending and Viscosity AgentsOrganic Chemicals • Oral Formulations
•
• Coating AgentsInorganic Chemicals • Topical Formulations
•
• BindersOther Products • Parenteral 
• Preservatives Formulations
• Emulsifying Agents • Other Formulations
• Other Functionalities
By Geography
North America Asia Pacific South America
• US • China • Brazil
• Canada • India • Argentina
• Mexico • South Korea • Rest of South America
• Japan
Europe • Australia
• Rest of Asia Pacific
• France
• Germany Middle East & Africa
• Italy
• UK • South Africa
• Spain • Saudi Arabia
• Rest of Europe • UAE
• Rest of Middle East and Africa
Leading Players
Company Profiles
• DuPont de Nemours, Inc.
• Roquette Frères
• Ashland Global Holdings, Inc.
• BASF SE
• Evonik Industries AG
• Associated British Foods Plc
• Archer Daniels Midland Company
• Lubrizol Corporation
• Croda International Plc
• DFE Pharma
  REASONS TO BUY
• Save and reduce time carrying out entry-level research by identifying the growth, size, leading 
players and segments in the Pharmaceutical Excipients market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global 
Pharmaceutical Excipients market, thereby allowing players across the value chain to develop 
effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and 
emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as 
well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security 
interest with respect to client products, segmentation, pricing and distribution.
      Pharmaceutical Excipients Market
        
Access Full Research Report at:
https://www.theinsightpartners.com/reports/pharmaceutical-excipients-
market/
Thank You! 
Thank You!